標普和納斯達克內在價值 聯繫我們

Response Oncology, Inc. ROIX OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Response Oncology, Inc. (ROIX) 是一家上市公司 屬於 醫療保健 板塊,經營於 Medical - Care Facilities 產業. 現任CEO為 Charles E. Sweet.

ROIX 擁有 IPO日期為 2000-01-03, 10 名全職員工, 在 Other OTC, 市值為 $12.00.

關於 Response Oncology, Inc.

Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.

公司詳情
所屬板塊醫療保健
細分行業Medical - Care Facilities
國家美国
交易所Other OTC
貨幣USD
IPO日期2000-01-03
首席執行官Charles E. Sweet
員工數10
交易資訊
當前價格$0.00
市値$12.00
52週區間1.0E-6-1.0E-6
Beta-19.14
ETF
ADR
CUSIP761232305
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言